Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-20T06:28:31.038Z Has data issue: false hasContentIssue false
  • English
  • Français

[No Title]

Published online by Cambridge University Press:  02 January 2018

A. Valmana  and
M. Potter
A. Valmana
Affiliation:
Springfield Hospital, 61 Glenburnie Road, London SW17
M. Potter
Affiliation:
Springfield Hospital, 61 Glenburnie Road, London SW17
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Sir: We welcome the recent Consensus Statement on the Use of High Dose Antipsychotic Medication (Thompson, 1994) but would welcome further guidance on the use of high dosages, particularly when polypharmacy is involved.

Type
Correspondence
Information
Psychiatric Bulletin , Volume 18 , Issue 10 , October 1994 , pp. 647
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1994

References

Foster, P. (1989) Neuroleptic equivalence. The Pharmaceutical Journal 243, 431–432 Google Scholar
Thompson, C. (1994) The use of high-dose antipsychotic medication. British Journal of Psychiatry, 164, 448–458 Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.